Skip to main content

Advertisement

Log in

Treatment of Patients with Stage IV Gastric Cancer

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

Treatment of patients with stage IV gastric cancer is controversial. This study was retrospectively designed to elucidate the best treatment for these patients.

Methods

Between 2003 and 2010, a total of 558 patients with gastric cancer were treated at the Department of Surgery, Tottori University Hospital, 96 (17.2 %) of whom were diagnosed with stage IV. Among 96, 54 underwent palliative gastrectomy while 42 underwent chemotherapy, exploratory laparotomy, or gastrojejunostomy for unresectable cases. Surgical morbidity, mortality, and patient survival were analyzed with respect to several factors.

Results

Among resected cases, high age, R2 operation, and neoadjuvant chemotherapy did not increase the occurrence of postoperative complications. Patient age, R1 operation, and sufficient chemotherapy were indicated as better prognostic factors for resected stage IV gastric cancers. Even after R2 operation, continuous chemotherapy with changing regimens prolonged R2 resected patients’ survival to 25 months (mean). In unresectable cases, bypass operation did not affect patients’ survival. But, chemotherapy with changing regimens prolonged the survival of unresectable cases.

Conclusions

Adequate management can resolve surgery-related morbidity, and continuous chemotherapy may be one of the most important prognostic factors in stage IV gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, et al. Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancet Oncol. 2006;7:309–15.

    Article  PubMed  CAS  Google Scholar 

  2. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069–77.

    Article  PubMed  CAS  Google Scholar 

  3. Medina-Franco H, Contreras-Saldívar A, Ramos-De La Medina A, Palacios-Sanchez P, Cortés-González R, Alvarez-Tostado Ugarte J. Surgery for stage IV gastric cancer. Am J Surg. 2004;187:543–6.

    Article  PubMed  Google Scholar 

  4. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.

    Article  PubMed  Google Scholar 

  5. Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2012. doi:10.1007/s10120-012-0163-4.

  6. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.

    Article  Google Scholar 

  7. Association JGC. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2010;14:113–23.

    Article  Google Scholar 

  8. Oñate-Ocaña LF, Méndez-Cruz G, Hwrnández-Ramos R, Becker M, Carrillo JF, Herrera-Goepfert R, et al. Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer. 2007;10:215–20.

    Article  PubMed  Google Scholar 

  9. Sougioultzis S, Syrios J, Xynos ID, Bovaretos N, Kosmas C, Sarantonis J, et al. Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis. Eur J Surg Oncol. 2011;37:312–8.

    Article  PubMed  CAS  Google Scholar 

  10. Hioki M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kinoshita T. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg. 2010;34:555–62.

    Article  PubMed  Google Scholar 

  11. Hartgrink HH, van de Velde CJ, Putter H, Songun I, Tesselaar ME, Kranenbarg EK, et al. Cooperating investigators of the dutch gastric cancer group. Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the dutch randomised FAMTX trial. Eur J Surg Oncol. 2004;30:643–9.

    Article  PubMed  CAS  Google Scholar 

  12. Okuyama T, Korenaga D, Koushi K, Itoh S, Kawanaka H, Ikeda Y, et al. The prognostic significance of chemotherapy for stage IV gastric cancer patients: a single-institution experience. Surg Today. 2011;41:935–40.

    Article  PubMed  CAS  Google Scholar 

  13. Ishigami S, Natsugoe S, Nakajo A, Matsumoto M, Uenosono Y, Arigami T, et al. Salvage gastrectomy following a combination of biweekly paclitaxel and S-1 for stage IV gastric cancer. J Gastrointest Surg. 2008;12:1370–5.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

All of the authors (Masahide Ikeguchi, Abdul Kader, Seigo Takaya, Youji Fukumoto, Tomohiro Osaki, Hiroaki Saito, Shigeru Tatebe, and Toshiro Wakatsuki) declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahide Ikeguchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikeguchi, M., Kader, A., Takaya, S. et al. Treatment of Patients with Stage IV Gastric Cancer. J Gastrointest Canc 44, 199–202 (2013). https://doi.org/10.1007/s12029-012-9471-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-012-9471-5

Keywords

Navigation